NAFLD is a chronic inflammatory disorder associated with increased hepatic expression of DPP-4; therefore, inhibition of DPP-4 could ameliorate NAFLD [16]. This evidence concerns the gene DPP4 and metabolic dysfunction-associated steatotic liver disease.